Skip to content

Deferred Taxes at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$10K-600%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$66.2M-51.1%
Incyte logo
IncyteINCY
$63.42M+1,046%
Eli Lilly logo
Eli LillyLLY
$1.48B+277%
Gilead Sciences logo
Gilead SciencesGILD
$179M+190%

Other financials

Income statement

See full
Revenue$164.9M+4.9%
Gross profit$162.0M+4.7%
Operating income-$49.6M-1,552%
Net income-$31.8M-255%
EPS (diluted)-$0.30-276%

Balance sheet

See full
Cash & equivalents$110.0M+21.1%
Total debt$9.6M+41.0%
Total equity$638.0M-6.6%
Total assets$814.9M-3.7%

Cash flow

See full
Operating cash flow-$16.8M-452%
CapEx$201.0K+93.3%
Free cash flow-$17.0M-464%

Valuation

See full
Market cap$8.58B-64.4%
Enterprise value$8.48B-65.0%
P/E181.2×+1.3×
P/S11.2×-24.0×

Profitability

See full
Gross margin98.3%-0.2pp
Operating margin-1.1%-17.2pp
Net margin6.2%-13.4pp
FCF margin15.6%-10.2pp

Returns & leverage

See full
Return on equity7.2%-14.6pp
Debt / equity0.0×
Current ratio2.9×-0.2×

Where this comes from

Reported directly by Corcept Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corcept Therapeutics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corcept Therapeutics's deferred taxes?
Corcept Therapeutics (CORT) reported deferred taxes of -$13.11M in Q1 2026.
How has Corcept Therapeutics's deferred taxes changed year-over-year?
Corcept Therapeutics's deferred taxes increased by 4.3% year-over-year, from -$13.71M to -$13.11M.
What is the long-term trend for Corcept Therapeutics's deferred taxes?
Over 3 years (2021 to 2024), Corcept Therapeutics's deferred taxes has grown at a 109.9% compound annual growth rate (CAGR), from $4.35M to -$40.19M.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.